SID 18: Organ Transplant
1⃣ Interplay Between Host Immune System & Immunosuppression
The core problem in transplant patients
Your immune system’s job is to detect foreign material and destroy it.
Unfortunately, a transplanted organ looks foreign to the immune system.
So the immune system tries to attack it → allograft rejection.
Transplant medicine therefore has to balance two competing risks:
⚖ Too little immunosuppression → organ rejection
⚖ Too much immunosuppression → infections & malignancy
This balance is shown conceptually in the lecture as a scale between:
Opportunistic infections and
Graft rejection.
Quick immune system refresher
Two arms of immunity matter here.
Innate immunity (fast)
Neutrophils
Macrophages
NK cells
Complement
Adaptive immunity (targeted)
T cells
B cells
Adaptive immunity is the main driver of transplant rejection.
Key functions:
Cell | Role |
|---|---|
CD4 T cells | coordinate immune response |
CD8 T cells | destroy infected/foreign cells |
B cells | produce antibodies |
Why immunosuppressants target T-cells
Transplant rejection is largely T-cell mediated.
T cells recognize donor antigens → activate cytokines → destroy graft tissue.
Therefore most transplant drugs aim to:
🛑 Block T-cell activation
🛑 Block T-cell proliferation
🛑 Reduce antibody formation
2⃣ Timing of Opportunistic Infections After Transplant
The type of infection strongly depends on how long after transplant the patient is.
Your exam will absolutely test this.
⏱ Infection timeline
Time after transplant | Typical infections |
|---|---|
Early (< 4 weeks) | Surgical / hospital infections |
Intermediate (1–12 months) | Opportunistic infections |
Late (>12 months) | Community infections |
Early period (<4 weeks)
Cause:
surgery
hospital exposure
donor infections
Common infections:
surgical wound infections
catheter infections
nosocomial pneumonia
UTIs
Usually bacterial.
Intermediate period (1–12 months)
This is when immunosuppression is highest.
Classic opportunistic infections appear:
🦠 Viruses
CMV
EBV
BK virus
HSV
🍄 Fungi
Candida
Aspergillus
Pneumocystis jirovecii
🦠 Bacteria
Listeria
Nocardia
Mycobacteria
Late period (>12 months)
Immunosuppression is lower.
Infections resemble general population infections:
community respiratory viruses
pneumonia
UTIs
Unless:
patient is over-immunosuppressed
graft rejection treatment increases immunosuppression
3⃣ Immunosuppressive Agents
Maintenance therapy usually uses 3 drugs together.
Why?
Different mechanisms → lower doses → fewer toxicities.
Typical regimen:
💊 Calcineurin inhibitor
💊 Antimetabolite
💊 Corticosteroid
3A️⃣ Calcineurin Inhibitors (CNIs)
Drugs:
Tacrolimus
Cyclosporine
These are the backbone of transplant therapy.
Mechanism
They block calcineurin, which prevents IL-2 transcription.
IL-2 is required for T-cell activation and proliferation.
Result:
🚫 ↓ T-cell activation
🚫 ↓ immune response
🚫 ↓ rejection
Differences
Feature | Tacrolimus | Cyclosporine |
|---|---|---|
Preference | Preferred | Used less often |
Metabolism | CYP3A4 | CYP3A4 |
Monitoring | trough levels | trough or C2 |
Unique ADRs | neurotoxicity, hyperglycemia | hirsutism, gingival hyperplasia |
Shared ADRs | nephrotoxicity, HTN |
Tacrolimus is usually preferred because it has:
✔ lower rejection rates
✔ better graft survival
3B️⃣ mTOR Inhibitor
Drug:
Sirolimus
Mechanism
Blocks mTOR, which stops cell cycle progression.
Result:
🛑 (STOPS) T-cell proliferation
🛑 (STOPS) B-cell proliferation
Important exam point
❗ NOT used immediately after transplant.
Why?
It causes:
impaired wound healing
thrombosis risk
delayed graft function
Therefore it's used when:
CNI toxicity occurs
malignancy develops
persistent rejection
3C️⃣ Antimetabolites
Drugs:
Mycophenolate
Azathioprine
These block DNA synthesis in immune cells.
Mycophenolate
Mechanism:
Blocks inosine monophosphate dehydrogenase (IMPDH) → prevents guanosine synthesis.
Result:
🚫 T-cell proliferation
🚫 B-cell proliferation
Common ADRs:
diarrhea
leukopenia
hepatotoxicity
Preferred agent because it causes less bone marrow toxicity than azathioprine.
Azathioprine
Prodrug → converted to 6-mercaptopurine.
Mechanism:
🧬 blocks purine synthesis → impaired DNA replication.
Main toxicity:
💀 bone marrow suppression
3D️⃣ Corticosteroids
Drug:
Prednisone
These have broad immunosuppressive effects.
They:
decrease lymphocyte activity
reduce antibody production
reduce inflammatory cytokines
Major steroid adverse effects
Common ones your prof might test:
hyperglycemia
osteoporosis
hypertension
weight gain
mood changes
infections
4⃣ Drug-Drug Interactions (Very High Yield)
Most immunosuppressants are metabolized by:
⚠ CYP3A4
So many interactions occur.
Drugs that DECREASE tacrolimus/cyclosporine levels
(CYP3A4 inducers)
Examples:
phenytoin
carbamazepine
phenobarbital
rifampin
Effect:
⬇ tacrolimus levels
⬇ immunosuppression
⚠ rejection risk
Management:
increase dose
monitor levels
Drugs that INCREASE tacrolimus levels
(CYP3A4 inhibitors)
Examples:
azole antifungals
macrolides
diltiazem
verapamil
amiodarone
ritonavir (Paxlovid)
Effect:
⬆ tacrolimus levels
⚠ toxicity (nephrotoxicity, neurotoxicity)
Management:
reduce dose
monitor troughs
5⃣ Opportunistic Infection Prophylaxis
Your exam will probably ask which prophylaxis to use.
CMV prophylaxis
Drug:
💊 Valganciclovir
MOA:
Nucleoside analogue → inhibits viral DNA polymerase.
Risk depends on donor/recipient status
Donor | Recipient | Risk |
|---|---|---|
– | – | Low |
+ | + or – | Intermediate |
**+ | –** | Highest risk |
High risk → prophylaxis 3–12 months.
HSV prophylaxis
Most severe reactivation occurs first month post-transplant.
Prophylaxis used when:
patient not receiving CMV prophylaxis
Drug:
💊 Valacyclovir
Duration:
~3 months
PJP prophylaxis
Most important opportunistic infection prophylaxis.
Preferred drug:
💊 TMP-SMX
Options:
Regimen |
|---|
1 SS daily |
1 DS three times weekly |
Duration:
12 months after transplant
lifelong in lung transplant
Alternatives if sulfa allergy:
dapsone
pentamidine
atovaquone
⭐ High-Yield Exam Summary
If I were writing your exam questions, these are the 10 things I would test.
1⃣ Immunosuppression = balance between rejection vs infection
2⃣ T-cells drive transplant rejection
3⃣ Infection timing
<4 weeks → surgical/hospital
1–12 months → opportunistic
12 months → community infections
4⃣ Maintenance regimen
CNI + antimetabolite + steroid
5⃣ Tacrolimus preferred over cyclosporine
6⃣ Calcineurin inhibitors block IL-2 transcription
7⃣ Mycophenolate blocks IMPDH
8⃣ Sirolimus blocks mTOR
9⃣ CYP3A4 interactions are critical
10⃣ Prophylaxis
CMV → valganciclovir
HSV → valacyclovir
PJP → TMP-SMX